Hospira Issues Nationwide Voluntary Recall of Certain Lots of Liposyn and Propofol Products That May Contain Particulate Matter
Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, is voluntarily recalling 85 lots of Liposyn II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20%, Liposyn III 30% and 73 lots of Propofol Injectable Emulsion 1% products that begin with the lot numbers 79 and 80 because some of the containers may contain particulate matter. The source of the particulate matter has been identified as stainless steel equipment used in the manufacturing process.

Centurion Medical Products - Premie Pack and Meconium Pack - Recall
Kits recalled because the pediatric tracheal tubes were manufactured with an internal diameter smaller than indicated on the label.

Synthes USA, Ti Synex II Vertebral Body Replacement - Class I Recall
Reports of loss of device height, which may result in nerve injury, increased pain, spinal compression fracture, failure of additional fixation, and/or need for surgery to modify the implanted device.